However, according to our data, we propose that the overexpression of TRAF4 could be an essential feature of tumor cells, where an elevated TRAF4 expression induces activation of the EGFR‐TRAF4‐MEKK3‐ERK5 axis as the dominant pathway to promote tumorigenesis. The gene discussed is EGFR; the disease is neoplasm.